|
|
||
| |
128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Tags
-
CirTran Secures $1.5 Million in Financing
CirTran Corporation, a full-service contract manufacturer of IT, consumer and consumer electronics products, announced recently that it has received $1.5 million in financing through a securities purchase agreement with Cornell Capital Partners.
Iehab J. Hawatmeh, founder and president of CirTran, said the funding agreement was based on a 5% secured debenture, due April 23, 2009. As part of the transaction, he said CirTran paid a commitment fee of $120,000 and a structuring fee of $15,000, with net proceeds to the company of $1,365,000.
“As CirTran moves forward with our strategic business plan into the fourth quarter and fiscal 2007, we will use these funds for general corporate and working capital,” Mr. Hawatmeh said. “This will include our off-shore manufacturing business, which focuses on the direct response/sold-on-TV marketplace, for our new marketing divisions, which concentrate on that market, and in our core contract technology-based manufacturing business in Salt Lake.”
Mr. Hawatmeh said that the agreement calls for Cornell, at its option, to convert all or part of the principal amount owed under the Debenture into shares of CirTran common stock at a conversion price equal to the lowest closing bid price for the 20 trading days immediately preceding the conversion date, except as otherwise set forth in the debenture. Cornell, he said, may also convert up to $500,000 worth of the principal amount, plus accrued interest of the Debenture, in any consecutive 30-day period when the price of CirTran stock is $0.03 per share or less at the time of conversion.
“CirTran is appreciative of the continued support of the private investment community,” said Mr. Hawatmeh. “Cornell has shown faith in CirTran and our strategic plan over years, as evidenced by this debenture which comes due in 2009. Most recently, ANAHOP, another private investor, has made multiple stock purchases and entered into a forward-looking program based on warrants and the future. Our primary goal,” he said, “is to continue to work to reward our shareholders and private investors alike.”
Leave a reply
Latest Headlines:
Saturday July 24, 2010
Investors Show Interest in Trillion Dollar Outdoor Lifestyles Industry as NBFog Closes Bridge Funding Round
Thursday July 22, 2010
Euthymics Biosciences Closes $24 Million in Series A Funding and Acquires DOV Pharmaceutical
Thursday July 22, 2010
MK Capital Leads $8 Million in Series C Funding for TopSchool
Wednesday July 21, 2010
NGP Energy Technology Partners Leads Undisclosed Dollar Amount in Series D Funding Round for LedEngin
Tuesday July 20, 2010
Santé Ventures Leads $6 Million in Series B Funding for EndoStim
Friday July 16, 2010
Round Table Healthcare Partners Closes $600 Million Equity Fund and $200 Million Capital Fund
Friday July 16, 2010
Trilliant Raises $106 Million in Growth Capital, Funding Round Led by Investor Growth Capital, Vantage Point, ABB, and GE
Thursday July 15, 2010
Polaris Venture Partners and New Enterprise Associates Lead $35 Million in Series B Funding for Travena
Bad Behavior has blocked 382 access attempts in the last 7 days.
